CHESAPEAKE GENOMIC SYSTEMS, LLC
Halethorpe, MD · Biotech · Private
In vitro DNA assembly technology (Heteroduplex Thermostable Ligase Assembly) for synthesizing large DNA fragments >50 kb up to 1 Mbp without homologous recombination
- Grants
- $1.4M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Heteroduplex thermostable ligation assembly: a new platform to rapidly generate large DNA molecules | $256,645 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Heteroduplex thermostable ligation assembly: a new platform to rapidly generate large DNA molecules | $256,645 | |
| Federal grant | Department of Health and Human Services · Phase I · A System for the Large‐scale Production of Membrane Proteins | $239,783 | |
| Federal grant | Department of Health and Human Services · Phase I · Vectorless supercoiled DNA: a new scalable abacterial in vitro system to improve gene therapy safety and production efficiency | $295,924 | |
| Federal grant | Department of Health and Human Services · Phase I · Synthetic circular supercoiled DNA: an alternative to plasmids for the production of lentiviral vectors for cell and gene therapies | $306,872 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1381 | INFLAMED, INC. | — | — |
| 1382 | XPOSE THERAPEUTICS, INC. | — | — |
| 1383 | REJUVENATION TECHNOLOGIES, INC. | — | — |
| 1384 | CHESAPEAKE GENOMIC SYSTEMS, LLC | — | — |
| 1385 | STRESS THERAPEUTICS, INC. | — | — |
| 1386 | Atrapos Therapeutics, LLC | — | — |
| 1387 | Mycosynthetix, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.